In this sense, the kidney disease: improving global outcomes recommendation that genetic screening should be a mandatory investigation for these patients is appropriate, especially if it is in the context of a panel of genes such as HNF1B, that include other diseases that may phenocopy GS. This evidence concerns the gene HNF1B and kidney disorder.